Posted inComunicati
Ribo Submits European Clinical Trial Application for a Novel Dual Targeting siRNA SR122 for Mixed and Severe Dyslipidemia, Further Strengthening Its Footprint in the Area of Lipid Disorder
COMUNICATO STAMPA - CONTENUTO PROMOZIONALE SUZHOU, China and MÖLNDAL, Sweden, Nov. 10, 2026 /PRNewswire/ --…
Continue Reading














